Difference between revisions of "Neuroscience"
From PiWiki
| Line 1: | Line 1: | ||
| + | [http://www.ncbi.nlm.nih.gov/pubmed/25001617 (2014) Regulatory mechanisms underlying the differential growth of dendrites and axons] | ||
| + | [[Media:2014_--_Regulatory_mechanisms_underlying_the_differential_growth_of_dendrites_and_axons.pdf] | ||
| + | |||
| + | :"Recent studies have uncovered two distinct types of regulatory mechanisms that differentiate dendritic and axonal growth: '''dedicated''' mechanisms and '''bimodal''' mechanisms. '''Dedicated''' mechanisms regulate either dendrite- specific or axon-specific growth; in contrast, '''bimodal''' mechanisms direct dendritic and axonal development in '''opposite''' manners." | ||
| + | |||
| + | |||
| + | |||
| + | |||
'''Shrooms''' | '''Shrooms''' | ||
| Line 8: | Line 16: | ||
'''DIHEXA''' | '''DIHEXA''' | ||
| − | [[Media:The_pro-cognitive_and_synaptogenic_effects_of_angiotensin_IV-derived_peptides_are_dependent_on_activation_of_the_hepatocyte_growth_factor-c-Met_system.pdf]] | + | [[Media:The_pro-cognitive_and_synaptogenic_effects_of_angiotensin_IV-:derived_peptides_are_dependent_on_activation_of_the_hepatocyte_growth_factor-c-Met_system.pdf]] |
'''Ashwagandha''' | '''Ashwagandha''' | ||
| Line 14: | Line 22: | ||
[http://www.ncbi.nlm.nih.gov/pubmed/12395110 Axon (or dendrite) predominant outgrowth induced by constituents from Ashwagandha] | [http://www.ncbi.nlm.nih.gov/pubmed/12395110 Axon (or dendrite) predominant outgrowth induced by constituents from Ashwagandha] | ||
| − | + | :"results suggest that axons are predominantly extended by withanolide A, and dendrites by withanosides IVand VI." | |
[[Media:2002_--_Axon-_or_dendrite-predominant_outgrowth_induced_by_constituents_from_Ashwagandha.pdf]] | [[Media:2002_--_Axon-_or_dendrite-predominant_outgrowth_induced_by_constituents_from_Ashwagandha.pdf]] | ||
| Line 20: | Line 28: | ||
[http://www.ncbi.nlm.nih.gov/pubmed/19594760 (2009) Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET] | [http://www.ncbi.nlm.nih.gov/pubmed/19594760 (2009) Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET] | ||
| − | + | :withanoside IV a.k.a. Sominone = GDNF-independent stimulator of the RET pathway and/or a novel modulator of RET signalling | |
Revision as of 22:19, 9 September 2014
(2014) Regulatory mechanisms underlying the differential growth of dendrites and axons [[Media:2014_--_Regulatory_mechanisms_underlying_the_differential_growth_of_dendrites_and_axons.pdf]
- "Recent studies have uncovered two distinct types of regulatory mechanisms that differentiate dendritic and axonal growth: dedicated mechanisms and bimodal mechanisms. Dedicated mechanisms regulate either dendrite- specific or axon-specific growth; in contrast, bimodal mechanisms direct dendritic and axonal development in opposite manners."
Shrooms
Potentiation of neuritogenic activity of medicinal mushrooms in rat pheochromocytoma cells
DIHEXA
Ashwagandha
Axon (or dendrite) predominant outgrowth induced by constituents from Ashwagandha
- "results suggest that axons are predominantly extended by withanolide A, and dendrites by withanosides IVand VI."
Media:2002_--_Axon-_or_dendrite-predominant_outgrowth_induced_by_constituents_from_Ashwagandha.pdf
- withanoside IV a.k.a. Sominone = GDNF-independent stimulator of the RET pathway and/or a novel modulator of RET signalling
